Transcatheter Aortic Valve Replacement for Aortic Valve Infective Endocarditis: A Systematic Review and Call for

Milos Brankovic1,2, Ashkan Hashemi1, Julia Ansari3

  • 1Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

Cardiology and Therapy
|April 20, 2023
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) may be a viable option for select patients with active aortic valve infective endocarditis (AV-IE) and prohibitive surgical risk. This review highlights TAVR

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Active aortic valve infective endocarditis (AV-IE) poses significant risks, with surgery often declined due to prohibitive surgical risk.
  • Transcatheter aortic valve replacement (TAVR) presents a potential alternative for high-risk patients with AV-IE.
  • TAVR may serve as a bridge-to-surgery or standalone therapy in carefully selected AV-IE cases.

Purpose of the Study:

  • To systematically analyze the existing literature on the application of TAVR in patients with active AV-IE.
  • To evaluate the feasibility and outcomes of TAVR in patients with AV-IE who are not surgical candidates.
  • To identify the role of TAVR as an adjuvant therapy for AV-IE in specific patient populations.

Main Methods:

  • Systematic literature search of PubMed/MEDLINE, Embase, and Cochrane databases (2002-2022).
  • Inclusion criteria focused on studies reporting TAVR use in active AV-IE.
  • Analysis of six eligible studies involving patients with prohibitive surgical risk and AV-IE.

Main Results:

  • Six studies met criteria, all involving male patients (mean age 71 years) with high surgical risk scores (STS 27, EuroSCORE 56).
  • All patients presented with severe or moderate aortic regurgitation and cardiogenic shock, often due to prosthetic valve endocarditis.
  • No in-hospital mortality or myocardial infarction; one stroke occurred within 30 days. Median event-free time was 9 months, with no deaths or reinfections.

Conclusions:

  • TAVR can be considered an adjuvant therapy for selected patients with acute heart failure secondary to AV-IE who have prohibitive surgical risk.
  • Current evidence supports TAVR for acute hemodynamic compromise in AV-IE, not for active infection control or septic embolization.
  • A prospective registry is crucial to further investigate the outcomes of this off-label TAVR indication.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
16
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
10
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
16
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
19
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
20
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15